Summary
WisdomTree BioRevolution Fund is an ETF - a fund traded on an exchange like a stock - run by WisdomTree. Positions inside: 90. The ten largest make up 28% of the fund.
- Yearly costs
- 0.45%
- Fund size
- $4.53M
- Positions
- 90
- Dividend yield
- 3.21%
- Running since
- 2021
What speaks for it
Nothing stands out in its favour.
What to watch
- 91% of the fund is in one sector (Healthcare).
- 85% of the fund is in one country (United States).
- In the last five years its price once dropped by 60% from its high.
- A small fund with $4.53M under management; small funds get closed more often.
- It trades little: only about $60.8K changes hands a day.
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- +2.0%
- 3 months
- +24%
- This year
- +43%
- 1 year
- +41%
- 3 years
- +76%
- 5 years
- -7.4%
- Avg. market cap
- $106.6B
- P/E
- -
- Forward P/E
- -
- P/S
- 8.3x
- P/B
- 4.7x
- P/FCF
- -
- EV/EBITDA
- -
- Dividend yield
- 0.29%
- ROIC
- -18.3%
- ROE
- -34.8%
- Gross margin
- -2.5%
- Operating margin
- -952.7%
- Net margin
- -555.0%
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 1.26
Weighted average of the 50 largest companies, which make up 78% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Widely spread- 1 LLEli Lilly LLY 3.6%
- 2 TWTwist Bioscience TWST 3.6%
- 3 TETempus AI, Inc. TEM 3.4%
- 4 NTNatera NTRA 3.0%
- 5 MRModerna MRNA 2.8%
- 6 IMImmunome, Inc. IMNM 2.7%
- 7 TMThermo Fisher Scientific TMO 2.5%
- 8 STStoke Therapeutics, Inc. STOK 2.2%
- 9 UTUnited Therapeutics UTHR 2.2%
- 10 TX10x Genomics, Inc. TXG 2.2%
Positions in the fund: 90. The ten largest make up 28% of it.
Composition as of Oct 31, 2026.
Where is it spread?
One sector dominatesBy sector
- Healthcare 91%
- Basic materials 5.4%
- Consumer defensive 3.4%
By country
- United States 85%
- United Kingdom 4.4%
- Switzerland 2.7%
- Germany 2.6%
- Other countries 5.8%
By company size
- Mega cap 12%
- Large cap 38%
- Mid cap 30%
- Small cap 18%
- Micro cap 1.0%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M.
Largest sector: Healthcare (91%). Largest country: United States (85%). Largest size group: Large cap (38%).
What does it cost me?
Usual costs- A year from $10,000
- $45.00
- Over 20 years
- $2,184
From every $10,000 invested the fund takes $45.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $2,184.
How has it done?
Losing value- A year on average, 5 years
- -1.5%
- Deepest drop
- -60%
- Yearly volatility
- 29%
Average yearly decline over the last five years: 1.5%. Deepest drop in these years: 60% below the earlier high.
Does it pay dividends?
Yes, it pays out- Yield
- 3.21%
- Payments a year
- 1
- Last payment
- $0.77
Over the last 12 months it paid $0.77 per share, which is 3.21% of today's price. The last payment was $0.77 on Dec 26, 2025.
Is it easy to buy and sell?
It trades little- Traded a day
- $60.8K
- Shares a day
- 2.5K
On an average day about $60.8K of the fund changes hands.
How expensive are the companies inside?
Rather expensive- Average Bulios Score
- 46 out of 100
Weight by Bulios Fair Price
- Undervalued 8.1%
- Fairly valued 6.0%
- Overvalued 86%
By Fair Price, 86% of the rated weight comes out as overvalued.
Counted from its largest companies (50), which make up 78% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.
Similar funds
Funds that hold much of the same. The overlap says how much of their weight they share with this fund.
| Fund | Domicile | Size | 1-year change | Dividends | ||
|---|---|---|---|---|---|---|
CU CURE.AX Global X - S&P Biotech ETF | Australia | 0.45% | $28.3M | +32% | Reinvests | 43% |
XB XBI SPDR S&P Biotech ETF | United States | 0.35% | $8.16B | +38% | Pays out | 43% |
TD TDNA T. Rowe Price Biotech ETF | United States | 0.55% | $9.96M | - | - | 38% |
GN GNMX Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF | United States | 0.35% | $2.08M | - | - | 35% |
IB IBB iShares Biotechnology ETF | United States | 0.44% | $11.5B | +37% | Pays out | 35% |
GN GNOM Global X - Genomics & Biotechnology ETF | United States | 0.50% | $113.1M | +53% | Pays out | 34% |
